The biomarker CD163 can predict mortality in blood samples from patients with acute on chronic liver failure, report scientists. Acute-on-chronic liver failure (ACLF) is a sudden deterioration of the liver function in a patient with liver cirrhosis accompanied by failure of one or more organ systems. This liver disease has a serious prognosis and the four-week mortality rate is 20-30%.
from Top Health News – ScienceDaily http://bit.ly/1RufYy3 via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1RCAc5n
No comments:
Post a Comment